ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Viral Determinants of Pathogen Induced Alloantibody Production

    R. Ruhil, O. Bulut, S. Talebagha, B. Oh, V. Lu, S. Knechtle, N. Iwakoshi

    Emory Transplant Center, Atlanta

    Background: The appearance of alloantibody can initiate the onset of rapid and destructive antibody-mediated rejection (AMR) or have no demonstrable acute effects. The factors determining…
  • 2013 American Transplant Congress

    CMV Serostatus Correlation with Early Kidney Allograft Transcriptome Change in the GOCAR Cohort

    A. Le Page, W. Zhang, B. Murphy, B. Nankivell, J. Chapman, P. O'Connell, S. Alexander, W. Rawlinson

    University of NSW, Randwick, Australia; Mt Sinai School of Medicine, New York; Westmead Hospital, Westmead, Australia; The Children's Hospital Westmead, Westmead, Australia

    Identifying transcriptional change in renal allografts infected with Cytomegalovirus (CMV) may be important in understanding CMV effects on graft rejection and injury.We examined transcriptional profiles…
  • 2013 American Transplant Congress

    Late Antibody-Mediated Rejection (AMR) after Kidney Transplantation

    M. Martina, F. Oppenheimer, I. Revuelta, J. Campistol Planas, M. Sole, J. Cid, F. Diekmann

    Nephrology, Hospital Clinic, Barcelona, Spain; Hematology, Hospital Clinic, Barcelona, Spain; Pathology, Hospital Clinic, Barcelona, Spain

    INTRODUCTION: Late AMR can develop at any time post kidney transplantation and represents a major challenge.OBJECTIVE: To characterize a series of kidney transplant recipients with…
  • 2013 American Transplant Congress

    Bortezomib Impacts T-Cell Signaling and Regulatory Pathways

    O. Moussa, M. Askar, H. Gebel, S. Flechner, D. Taber, K. Chavin, P. Baliga, T. Srinivas

    Med. Univ South Carolina, Charleston; Cleveland Clinic, Cleveland; Emory University, Atlanta

    Introduction/ Aims: Bortezomib (PS-341), a selective 26S proteasome inhibitor has been used to treat antibody mediated rejection (AMR) among allograft recipients. The efficacy of Bortezomib…
  • 2013 American Transplant Congress

    Outcomes in Lung Transplantation: The RIFLE Classification Optimizes the Predictive Utility of Post-Transplant Acute Kidney Injury as a Determinant of Early and Late Outcomes

    A. Osho, A. Castleberry, L. Snyder, S. Palmer, S. Lin, R. Davis, M. Hartwig

    Department of Surgery, Duke University Medical Center, Durham, NC; Department of Medicine, Duke University Medical Center, Durham, NC

    The purpose of this study is to compare two methods of classifying acute kidney injury (AKI), the Risk, Injury, Failure, Loss, End stage (RIFLE) and…
  • 2013 American Transplant Congress

    Validating the Microarray Test for Antibody-Mediated Rejection in a Prospective Trial: The INTERCOM Study

    A. Pereira, J. Reeve, J. Chang, A. Matas, D. de Freitas, J. Bromberg, J. Sellares, G. Einecke, P. Halloran

    University of Alberta, Edmonton, Canada; University of Minnesota, Minneapolis; Manchester Royal Infirmary, Manchester, United Kingdom; University of Maryland School of Medicine, Baltimore; Hospital de la Vall d'Hebron, Barcelona, Spain; Medical School of Hannover, Hannover, Germany

    We previously developed a microarray-based test for antibody-mediated rejection (ABMR) in biopsies from renal transplants. To validate it, we undertook the INTERCOM study, a prospective…
  • 2013 American Transplant Congress

    Cytokine Measurement by High-Sensitivity Milliplex Assay in Cell Suspensions Obtained during Usual Kidney Allograft Biopsies

    N. Leca, S. Anderson, K. Muczynski

    Division of Nephrology, University of Washington, Seattle, WA

    PURPOSE: The purpose of the study was to determine if cytokines could be measured from the supernatant of kidney biopsy cell suspensions and if measured…
  • 2013 American Transplant Congress

    Alloantibody-Induced C4d Deposition, without Activation of Distal Complement Effectors C5a and C5b-9, Is Not Associated with Kidney Allograft Injury or Accommodation in Mice

    A. Chow, S. Husain, J. Pearcey, A. Raghuveer, T. Ho, P. Blanco, L. Zhu, B. Sis

    University of Alberta, Edmonton, Canada

    Complement split product C4d deposition in human organ transplants is a biomarker of classical complement activation triggered by antibody binding to donor antigens, but this…
  • 2013 American Transplant Congress

    Sitagliptin, DPP- IV Inhibitor, Protects Against Tacrolimus-Induced Diabetes in Rats

    L. Jin, S. Piao, K. Doh, S. Lim, S. Heo, B. Chung, C. Yang

    Convergent Research Consortium for Immunologic Disease, Seoul, Republic of Korea; Transplantation Research Center, Seoul, Republic of Korea; Division of Nephrology, Department of Internal Medicine, Seoul St. Mary&s Hospital, The Catholic University of Korea, Seoul, Republic of Korea; Nephrology & Dialysis Unit, Department of Internal Medicine, Affiliated Hospital, YanBian University Medical College, Jilin, China

    The pathogenesis of post-transplant diabetes mellitus is thought to be partly related to the direct toxic effect of tacrolimus on pancreas and the resultant decrease…
  • 2013 American Transplant Congress

    Splenic Artery Embolization in Liver Transplantation: A Single Center 5 Year Experience

    N. Presser, C. Tom, C. Quintini, Q. Liu, N. Ahmed, D. Kelly, K. Hashimoto, F. Aucejo, B. Eghtesad, C. Miller

    Liver Transplantation, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH; School of Medicine, Case Western Reserve University, Cleveland, OH

    Background:Severe portal hyperperfusion after liver transplantation has been shown to cause intrahepatic arterial vasoconstriction secondary to increased washout of adenosine (hepatic artery buffer response). Furthermore,…
  • « Previous Page
  • 1
  • …
  • 117
  • 118
  • 119
  • 120
  • 121
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences